HLS Therapeutics Inc. (T:HLS*CA)

Business Focus: Retail - Drugs without Grocery

INK Ultra Money Free

Latest 10 SEDI filings (by transaction date) for HLS*CA within the last 6 months
[?]
Amended Filing
As of 11:59pm ET February 25th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 17/20 Jan 15/20 Athyrium Opportunities II Co-Invest 1 LP Direct Ownership Common Shares 54 - Exercise of warrants 226,782  
Jan 17/20 Jan 15/20 Athyrium Opportunities II Co-Invest 1 LP Direct Ownership Warrants 54 - Exercise of warrants -525,409  
Jan 7/20 Jan 2/20 Orbimed Advisors, LLC Control or Direction Warrants 54 - Exercise of warrants -63,192 $0.009
USD
Jan 7/20 Jan 2/20 Orbimed Advisors, LLC Control or Direction Common Shares 54 - Exercise of warrants 63,163 $0.009
USD
Jan 7/20 Jan 2/20 Orbimed Advisors, LLC Control or Direction Warrants 54 - Exercise of warrants -189,576 $0.009
USD
Jan 7/20 Jan 2/20 Orbimed Advisors, LLC Control or Direction Common Shares 54 - Exercise of warrants 189,489 $0.009
USD
Jan 7/20 Jan 2/20 Orbimed Advisors, LLC Control or Direction Warrants 54 - Exercise of warrants -63,192 $0.009
Jan 7/20 Jan 2/20 Orbimed Advisors, LLC Control or Direction Common Shares 54 - Exercise of warrants 63,163 $0.009
Dec 20/19 Dec 18/19 Orbimed Advisors, LLC Control or Direction Common Shares 10 - Disposition in the public market -369,110 $19.25
Dec 20/19 Dec 18/19 Orbimed Advisors, LLC Control or Direction Common Shares 10 - Disposition in the public market -123,076 $19.25
Sign up or login above to see all SEDI filings within the past 6 months.
Latest 10 SEDI filings (by filing date) for HLS*CA within the last 6 months
[?]
Amended Filing
As of 11:59pm ET February 25th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 17/20 Jan 15/20 Athyrium Opportunities II Co-Invest 1 LP Direct Ownership Common Shares 54 - Exercise of warrants 226,782  
Jan 17/20 Jan 15/20 Athyrium Opportunities II Co-Invest 1 LP Direct Ownership Warrants 54 - Exercise of warrants -525,409  
Jan 7/20 Jan 2/20 Orbimed Advisors, LLC Control or Direction Warrants 54 - Exercise of warrants -63,192 $0.009
USD
Jan 7/20 Jan 2/20 Orbimed Advisors, LLC Control or Direction Common Shares 54 - Exercise of warrants 63,163 $0.009
USD
Jan 7/20 Jan 2/20 Orbimed Advisors, LLC Control or Direction Warrants 54 - Exercise of warrants -189,576 $0.009
USD
Jan 7/20 Jan 2/20 Orbimed Advisors, LLC Control or Direction Common Shares 54 - Exercise of warrants 189,489 $0.009
USD
Jan 7/20 Jan 2/20 Orbimed Advisors, LLC Control or Direction Warrants 54 - Exercise of warrants -63,192 $0.009
Jan 7/20 Jan 2/20 Orbimed Advisors, LLC Control or Direction Common Shares 54 - Exercise of warrants 63,163 $0.009
Dec 20/19 Dec 17/19 Orbimed Advisors, LLC Control or Direction Common Shares 10 - Disposition in the public market -220,600 $19.00
Dec 20/19 Dec 18/19 Orbimed Advisors, LLC Control or Direction Common Shares 10 - Disposition in the public market -369,110 $19.25
Sign up or login above to see all SEDI filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider.
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $HLS.CA

  • No tweets found

Competitors

Competitors with Recent Insider Filings
iAnthus Capital Holdings (C:IAN*CA)